Our group have previously reported that GPS, which is calculated using serum C‐reactive protein and albumin, can predict the prognosis and exacerbation of ILD in patients with ILD‐complicated lung cancer,14, 15 suggesting the potential involvement of inflammation and nutrition in the pathophysiology of this disease. Here, ALB is linked to interstitial lung disease.